The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global protein purification and isolation market size reached US$ 7.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 13.4 Billion by 2027, exhibiting a growth rate (CAGR) of 9.91% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Protein purification and isolation refer to a series of processes undertaken for isolating a type of protein from a complex mixture of cells, organisms, or tissues. These processes are mandatory for performing protein studies, which isolate, concentrate, stabilize, and remove impurities like nucleic acid, endotoxins, and viruses. They involve determining the initial material and maintaining a purification table to track the progress of the enzyme. They are primarily utilized for the classification of the function, structure, and interactions of the protein. Some of the commonly used methods of protein purification and isolation include affinity chromatography, immunoprecipitation, proteomics, or enzyme assay.
The burgeoning pharmaceutical industry across the globe represents one of the primary factors strengthening the growth of the market. Besides this, governing agencies of numerous countries are coming up with favorable initiatives to provide tax incentives, grants, and investment-friendly regulations to the pharmaceutical and biotechnology sector. These initiatives are positively influencing the manufacturers to engage in the research and development (R&D) activities for the development of novel drugs, which is significantly contributing to the market growth. Furthermore, there is a rise in the need for identifying new ligands and the development of purification kits that assist in the screening, preparing, purifying, and concentrating of protein samples. This is acting as another growth-inducing factor. Moreover, several technological advancements, including the introduction of magnetic and protein beads, ligand tagging systems, and automated analyzers, are creating a favorable market outlook. Other major factors like rising research initiatives in academic institutes for structural and functional proteomics, detailed kinetic analysis, and the increasing number of preclinical trials outsourced by drug development companies are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global protein purification and isolation market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technology, product, application and end user.
Breakup by Technology:
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Company, Merck KGaA, Norgen Biotek Corp., Promega Corporation, Purolite, Qiagen N.V. and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Technology, Product, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abcam plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Company, Merck KGaA, Norgen Biotek Corp., Promega Corporation, Purolite, Qiagen N.V. and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at